baber/WOPTO huggingface dataset:
Patent CA-2720431-A1 (CA)
Inventor: WEGELIN JACKSON W
IPC: A47K5/12
Filed: 2010-11-09
Abstract: Various methods are disclosed for resetting a stalled pump in a fluid dispensing system. In one embodiment, it is determined whether a refill container is received in the dispensing system and then a pump actuator is moved to a loading position when the refill container is removed. Another method sets a run timer, starts a pump actuator, determines whether the pump actuator is still dispensing fluid from the fluid dispensing system upon lapsing of the run timer and then moves the pump actuator if the pump actuator is still dispensing upon the expiration of the run timer. And another method detects opening of a cover, energizes a motor to move an actuator to a loading position, determines when the actuator is at the loading position and then turns the motor off.
Patent CA-2721056-A1 (CA)
Title: Method for providing a nanocellulose involving modifying cellulose fibers
Inventor: ANKERFORS MIKAEL
IPC: A23L29/20
Filed: 2009-04-08
Abstract: The present invention provides a method for the manufacturing of nanocellulose. The method includes a first mod-ification of the cellulose material, where the cellulose fibres are treated with an aqueous electrolyte-containing solution of an am-photeric cellulose derivative. The modification is followed by a mechanical treatment. By using this method for manufacturing nanocellulose, clogging of the mechanical apparatus is avoided. Also disclosed is nanocellulose manufactured in accordance with said method and uses of said cellulose.
Patent CA-2721717-A1 (CA)
Title: An improved turbine installation method
Inventor: IVES JAMES
IPC: H02G9/12
Filed: 2009-04-16
Abstract: The present invention provides a method of installing a hydroelectric turbine onto the seabed or the like while ensuring that a pre-laid electrical cable connected to the turbine prior to lowering to the seabed is not damaged during installation of the turbine, the method involving lowering the turbine towards the seabed while simultaneously displacing the turbine in order to maintain tension in the electrical cable.
Patent CA-2723028-A1 (CA)
Title: Phosphate de lanthane et d'au moins une terre rare choisie parmi le cerium et le terbium sous forme d'une suspension, procede de preparation et utilisation comme luminophore
Inventor: BUISSETTE VALERIE
IPC: C09K11/77
Filed: 2009-05-13
Abstract: Le phosphate de l'invention est un phosphate de terre rare (Ln), Ln représentant au moins une terre rare choisie parmi le cérium, le terbium ou le lanthane en combinaison avec au moins l'une des deux premières terres rares précitées, caractérisé en ce qu'il se présente sous forme d'une suspension dans une phase liquide de particules primaires de taille moyenne d'au moins 25 nm, isotropes, monocristallines, du type monazite, agglomérées en particules secondaires, de taille moyenne d'au plus 400 nm. Ce phosphate peut être utilisé comme luminophore.
Patent CA-2723388-A1 (CA)
Inventor: LUCHT BRETT L
IPC: C08G61/00
Filed: 2009-05-07
Abstract: Provided herein are novel polythiophene compounds having polyalkoxyl sidechains and low temperature irreversible upon activation (I UA) thermochromic compounds/compositions thereof The NA  thermochromic compounds or compositions are activated and exhibit an IUA color by heating to or above a reversible thermochromic transition temperature (RTTT) and cooling to or below an irreversible thermochromic transition temperature (IRTTT) in less than 2 seconds The activated IUA  thermochromic compounds or compositions will retain their IUA color as long as the compounds or compositions are kept at or below about 5 degreeC below the IRTTT The IUA thermochromic compounds/composition can be used to prepare IUA thermochromic indicators which can monitor subjects stored below a pre-determined temperature and detect the subjects that have been exposed to a temperature above the pre-determined temperature.
Patent CA-2724231-A1 (CA)
Title: Novel targets for regulation of angiogenesis
Inventor: DEMORE NANCY KLAUBER
IPC: C12Q1/68
Filed: 2009-05-15
Abstract: The present invention relates to the identification of polynucleotides and polypeptides having increased expression in tumor blood vessels. The invention further relates to the use of the identified polynucleotides and polypeptides, and inhibitors of the polynucleotides and polypeptides, in the regulation of angiogenesis and the diagnosis and treatment of angiogenesis-related diseases such as cancer.
Patent CA-2724972-A1 (CA)
Inventor: DONDE YARIV
IPC: C07D295/088
Filed: 2009-05-01
Abstract: Compounds comprising (I) or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
Patent CA-2725120-A1 (CA)
Inventor: MIYABE SHIGEO
IPC: G03G15/08
Filed: 2009-06-09
Abstract: A cartridge for use with a main assembly of an electrophotographic image forming apparatus, the main assembly including a driving shaft having a rotational force applying portion, wherein the cartridge is dismountable from the main assembly in a direction substantially perpendicular to an axial direction of the driving shaft, the cartridge including i) a developing roller that is rotatable about an axis thereof; and ii) a coupling member (150) engageable with the rotational force applying portion (180) to receive a rotational force for rotating the developing roller, the coupling member being capable of taking a rotational force transmitting angular position (fig.18b) for transmitting the rotational force for rotating the developing roller and a disengaging angular position (fig.18a) in which the coupling member is inclined away from the rotational force transmitting angular position, wherein when the cartridge is dismounted from the main assembly, the coupling member moves from the rotational force transmitting angular position to the disengaging angular position.
Patent CA-2725423-A1 (CA)
Inventor: SALINAS JAMES J
IPC: G06F11/00
Filed: 2009-05-01
Abstract: Generally, a computer implemented remote monitoring system which generates a viewable reduced byte data representation for each one of a plurality of analyzed instrument signals.   Specifically, a flow cytometer remote monitoring system which generates a viewable reduced byte data representation for each one of a plurality analyzed flow cytometer signals.
Patent CA-2726429-A1 (CA)
Inventor: ALLISON GREGORY
IPC: A47C3/30
Filed: 2009-06-05
Abstract: A height adjustment mechanism is disclosed that includes a pedestal (1) height variability mechanism (10). The pedestal (1) height variability mechanism (10) includes a first member (17) and a biasing mechanism (5). The biasing mechanism (5) is configured to hold the first member (17) in a first position. The first member (17) has a first end (27) and a second end (29) opposite the first end (27). The biasing mechanism (5) has a first portion (7) attached to the first member (17) adjacent the first end (27) of the first member (17). The biasing mechanism (5) also has a second portion (9) attached to the first member (17) adjacent to the second end (29) of the first member (17). Preferably, a second member (18) is also provided that is moveably attached to the first member (17). The second member (18) may be configured such that movement of the second member (18) actuates height adjustment of a chair.
Patent CA-2727450-A1 (CA)
Inventor: ZOSS ROBERT A
IPC: B65D85/80
Filed: 2009-06-10
Abstract: Describe are food packages having features such as multiple containers in a single package and multiple pieces for a package; the packages can contain multiple food products including (for example) cereal and milk, for consumption together in a convenient manner.
Patent CA-2727631-A1 (CA)
Title: Dispositif de reglage du taux de compression a levee de bille pour moteur a taux de compression variable
Inventor: RABHI VIANNEY
IPC: F02B75/32
Filed: 2009-06-26
Abstract: Le dispositif de réglage du taux de compression d'un moteur à taux de compression variable comprenant un vérin de commande hydraulique à double effet (8) comportant une chambre supérieure (121) et une chambre inférieure (122) et au moins un piston de vérin (13) relié à une crémaillère de commande (7) comprend : Au moins deux billes (401, 402) ou clapets reposant chacune sur un siège (403, 404) et obturant respectivement l'une et l'autre extrémité d'un canal de transfert (405) reliant la chambre supérieure (121) et la chambre inférieure (122) du vérin de commande (8), lesdites billes (401, 402) agissant comme un clapet anti-retour lorsqu'elles sont maintenues sur leur siège (403, 404) par un ressort (408, 409) afin de ne laisser passer le fluide hydraulique que dans un sens; Et des moyens de levage (410) permettant de soulever les billes (401, 402) de leur siège (403, 404) pour que lesdites billes laissent passer le fluide hydraulique dans les deux sens.
Patent CA-2728181-A1 (CA)
Inventor: LEARY RICHARD MAURICE
IPC: G06F17/30
Filed: 2008-12-22
Abstract: A method of identifying a network of actors within a data set, the method comprising: -importing data from one or more data sources; -normalising the data in one or more fields to create a consolidated data set; -identifying one or more networks based on identical or similar instances of one or more pieces of data in the consolidated data set; and -calculating a measure of influence of one or more of the actors in an identified network.
Patent CA-2728831-A1 (CA)
Inventor: RAY PINAKI
IPC: G16H20/70
Filed: 2011-01-18
Abstract: A system and method are shown and described for outputting a customized health data report with minimal usage of a user interface.
Patent CA-2729135-A1 (CA)
Title: Re-useable auto-injector with filling means
Inventor: JENNINGS DOUGLAS IVAN
IPC: A61M5/20
Filed: 2009-06-10
Abstract: An injection device having a first sub-assembly (110) comprises a housing (111) and a chamber (112). The chamber is disposed within the housing and has proximal and distal ends, an inner surface and an exit aperture (114). The sub-assembly comprises a stopper (113) movably disposed within the chamber. The stopper has an outer surface substantially in contact with the inner surface about its perimeter. The sub-assembly comprises a port (118) adapted to receive a container (1199) containing a fluid. The stopper is fixed with respect to the housing and movement of the port causes movement of the exit aperture in relation to the stopper.
Patent CA-2729646-A1 (CA)
Inventor: AMEER GUILLERMO A
IPC: A61L31/04
Filed: 2009-07-02
Abstract: Controlled release vascular implants, such as vascular grafts, stents, wraps, and gels comprising a biocompatible polymer and all trans retinoic acid (ATRA), or its derivatives, can be used to treat, prevent, or inhibit thrombosis and/or neointimal hyperplasia which may otherwise be induced by prosthetic implantation. In particular, the implants herein can inhibit smooth muscle cell proliferation, neointimal hyperplasia, and upregulate antithrombotic genes and nitric oxide production in the vasculature.  Further, the implants are capable of delivering controlled and predictable localized concentrations of ATRA.
Patent CA-2730089-A1 (CA)
Inventor: VON OHLSEN JON
IPC: G06F1/02
Filed: 2009-07-09
Abstract: Apparatus and method for providing and using a highly precise and low level driver. In one described embodiment, a driver for a magnetic field generating device is provided, the driver including a first digital to analog converter and a second digital to analog converter; a differential amplifier configured to receive a first signal from the first digital to analog converter and receive a second signal from the second digital to analog converter and output a third signal; and an attenuator to configured to receive the third signal from the differential amplifier.
Patent CA-2730268-A1 (CA)
Inventor: LAFAYE PIERRE
IPC: C07K16/30
Filed: 2009-07-10
Abstract: The present invention relates to the use of variable domains of camelid heavy-chain antibodies (VHH domains) di-rected against an intracellular target and having an isoelectric point of at least 8.5, for targeting said intracellular target or for the preparation of a peptide vector. Particularly, it concerns VHH domains directed against a glial fibrillary acidic protein and uses thereof for preparing therapeutic or diagnostic agents.
Patent CA-2732464-A1 (CA)
Inventor: NEGULESCU DIMITRIE
IPC: F02C3/13
Filed: 2011-02-23
Abstract: The invention refers to an aircraft gas turbine engine including a core engine comprising at least a high pressure turbine 6 and a downstream low pressure turbine 7, a bypass duct 18 surrounding the core engine 1, as well as a mixer 19 arranged in an inlet portion of the low pressure turbine 7, into which a bypass flow 20 from the bypass duct 18 and a core flow 22 from the core engine 1 are supplied.
Patent CA-2733772-A1 (CA)
Title: A system for anesthetizing whilst attuning the temperature of mammals and methods thereof
Inventor: RAPOPORT URI
IPC: A61N1/30
Filed: 2009-08-12
Abstract: The present invention discloses methods and a system for anaesthetizing mammals in a thermoregulated confined volume. The system comprises at least one chamber confining a volume in size and shape for accommodating at least one mammal;  supplying mechanism for supplying at least one anesthetizing vapor to said at least one chamber; temperature controlling mechanism, in communication with said vapor supplying means, adapted to thermoregulate said vapor to temperature T; and a vapor introducing mechanism, coupled to said supplying means and to said at least one chamber, adapted to introduce said thermoregulated vapor to said at least one chamber; wherein the temperature T  within said confined volume is regulated by said thermoregulated vapor.
Patent CA-2736876-A1 (CA)
Inventor: MILLER STEVEN A
IPC: B22F9/00
Filed: 2009-09-02
Abstract: Refractory metal powders are dehydrided in a device which includes a preheat chamber for retaining the metal powder fully heated in a hot zone to allow diffusion of hydrogen out of the powder. The powder is cooled in a cooling chamber for a residence time sufficiently short to prevent re-absorbtion of the hydrogen by the powder. The powder is consolidated by impact on a substrate at the exit of the cooling chamber to build a deposit in solid dense form on the substrate.
Patent CA-2739351-A1 (CA)
Inventor: ALSHAER HISHAM
IPC: A61B5/08
Filed: 2009-11-16
Abstract: Disclosed herein is a method and apparatus for monitoring, identifying and determining the breathing cycle of an individual from processed acoustic signal waveform data. The breathing sounds of an individual are recorded using a microphone and digitized such that the breathing sounds may be plotted. The data is segmented and transformed to form a plurality of segments representative of a frequency spectrum. The frequency spectrum data is transformed so as to produce magnitude bins and the sum of lower magnitude bins and the sum of higher magnitude bins are determined in a sampling of segments. A Bands Ratio is determined from the sum of lower magnitude bins and the sum of higher magnitude bins in the sampling of segments. A first bands ratio is then determined within a given segment and compared to the mean bands ratio. If the first bands ratio of the given segment is greater than the mean bands ratio by at least a predetermined multiplier, the given segment is labeled as inspiration. If the first bands ratio of the given segment is less than the mean bands ratio by at least a predetermined multiplier, the given segment is labeled as expiration.
Patent CA-2742620-A1 (CA)
Title: Haptic output device for use with haptic encoded media
Inventor: ALARCON RAMON
IPC: G06F3/00
Filed: 2009-10-09
Abstract: Methods, systems, and apparatus for generating sensations in response to haptic data. A sensation output device can include a processor adapted to generate one or more control signals corresponding to a haptic command, an actuator adapted to output a force to a drive mechanism in response to one or more control signals received from the processor, an opening through which a portion of a user's body can be inserted, and an interface surface coupled to the drive mechanism, the interface surface configured to at least partially contact the inserted portion of the user's body. Further, the interface surface can be a compliant belt having surface features that is coupled with a carrier belt that is in contact with the drive mechanism. Additionally, the sensation output device can include a memory storing an algorithm including one or more haptic commands, which can be executed by the processor.
Patent CA-2743287-A1 (CA)
Title: Articles and methods for laying ceramic tile floor
Inventor: D AGOSTINO JOSEPH D
IPC: E04F15/022
Filed: 2011-06-15
Abstract: Ceramic floors and methods of making thereof such that the ceramic tiles are quickly and easily removable from the floor substrate and replaceable at a future date. A plurality of pre-fabricated articles each comprising a sheet and one or more ceramic tiles bonded to the sheet are laid onto the floor with sheet edges abutting, and the sheets are bonded to the floor substrate with releasable adhesive. The tile edges are set inwardly from the sheet edges so that a tile of one article is spaced from a tile of another article when the articles are laid. A non-Portland cement grout, preferably urethane grout, is provided between adjacent tiles. A plurality of pre-fabricated articles each comprising a backer board, a sheet, and a releasable adhesive bonding the sheet to the upper surface of the backer board, the sheet covering the entirety of the upper surface. After these articles are applied to the floor substrate, ceramic tiles are bonded to the sheets. A plurality of pre-fabricated articles each comprising a sheet bonded to the upper surface of a backer board. After these articles are applied to the floor substrate, ceramic tiles are bonded to the sheets. Each sheet comprises a plurality of layers bonded together wherein separation of the sheet along layers thereof is effected for removal of laid ceramic tiles from the backer board.
Patent CA-2745019-A1 (CA)
Title: Quinolone compound and pharmaceutical composition
Inventor: OTSUBO KENJI
IPC: C07D401/12
Filed: 2009-12-04
Abstract: The present invention provides a quinolone compound that inhibits the chronic progression of Parkinson's disease or protects dopamine neurons from disease etiology, thereby suppressing the progression of neurological dysfunction, so as to prolong the period of time until L-dopa is administered while also improving neuronal function; the quinolone compound of the invention is represented by Formula (1): wherein: R1 represents hydrogen or the like; R2 represents hydrogen or the like; R3 represents substituted or unsubstituted phenyl or the like; R4 represents halogen or the like; R5 represents hydrogen or the like; R6 represents hydrogen or the like; and R7 represents hydrogen or the like.
Patent CA-2748659-A1 (CA)
Inventor: SHALHEVET DAVID
IPC: A01N63/00
Filed: 2004-04-29
Abstract: Embodiments of the present invention provide Dermal Micro Organs (DMOs), methods and apparatuses for producing the same. Some embodiments of the invention provide a DMO including a plurality of dermal components, which substantially retain the micro-architecture and three dimensional structure of the dermal tissue from which they are derived, having dimensions selected so as to allow passive diffusion of adequate nutrients and gases to cells of the DMO and diffusion of cellular waste out of the cells so as to minimize cellular toxicity and concomitant death due to insufficient nutrition and accumulation of waste in the DMO. Some embodiments of the invention provide methods and apparatuses for harvesting the DMO. An apparatus for harvesting the DMO  may include, according to some exemplary embodiments, a support configuration to support a skin-related tissue structure from which the DMO is to be harvested, and a cutting tool able to separate the DMO from the skin-related tissue structure. Other embodiments are described and claimed.
Patent CA-2748942-A1 (CA)
Inventor: KIM JONG WOO
IPC: A61K36/346
Filed: 2010-01-21
Abstract: The present invention relates to a pharmaceutical composition for preventing or treating Hepatitis C, comprising the roots extract of Platycodon grandiflorum and/or saponin components in Platycodon grand florum useful as an antiviral agent.  The composition of the present invention has no harm to human and inhibits the proliferation of Hepatitis C virus, so that it can be effectively used as a preventive or therapeutic agent for Hepatitis C.
Patent CA-2749071-A1 (CA)
Inventor: HILLIAM KENNETH G
IPC: F16D71/00
Filed: 2011-08-11
Abstract: This invention operates in some ways very similar to a Stepper Motor. The main difference is that the Final Step or Load Position is reached directly in one continuous motion without employing evenly spaced Rotor Sequencing Steps. The invention also offers the option to select any Non-Stepper Motor which has the best operating characteristics for the required design. Motor Characteristics may be as follows: Starting or Running Torque, Speed, Power, Wattage, Duty Cycle, Breaking, Cooling, Size, Current, Voltage, Maintenance and Cost.   The Load can be disconnected from the Rotor Shaft by an Intermediate Clutch.  The Load has less Inertia because the Motor is disconnected by the Intermediate Clutch.  This invention runs cooler and more efficiently because the Load can be held by a Residual Field Magnet without using continuous holding Power. The Motor can be continuously running because the Intermediate Clutch is a rotating holding magnetic link between the Motor and the Load.   An Optical Sensor Counter counts the rotating Number of Reflectors on the Load Disk or the Light Beams which pass through Slots on a Load Cutch Disk or on a Motor Disk.  The Count Number represents the Terminal Angle or Final Load Position and this number is fed to a Controller. The Controller in turn controls through Binary Logic three Electro-Magnetic Clutches. One Motor Clutch controls whether the Motor must be stopped or continue to rotate. A second, Intermediate Clutch, links the Motor Rotation to the Load and permits the Load to rotate at the same Speed as the Motor. The energized Load Clutch prevents the Load from rotating when the Intermediate Clutch links the rotating Motor and the Load. The Load Clutch must prevent the Load Output from rotating if the Intermediate Clutch is disengaged.  The Motor Clutch is employed to stop the Motor from rotating through damping or more forcefully depending on the Speed of the Motor, the Running Torque and the Angle or Radian Count. This invention isolated the Motor and the Load Characteristics from each other so that the designer has more opportunities by employing more advantages and to in many situations to run the Motor more efficiently when the Load is disengaged eg. breaking.
Patent CA-2751396-A1 (CA)
Title: Method and system for determining the quality of pharmaceutical products
Inventor: SINBAR ERAN
IPC: G01N33/15
Filed: 2010-02-04
Abstract: Thermographic imaging is used to monitor quality parameters of pharmaceutical products (108 in a manufacturing process.
Patent CA-2752499-A1 (CA)
Title: Vapor collection and barrier systems for encapsulated control infrastructures
Inventor: DANA TODD
IPC: C10G99/00
Filed: 2010-02-05
Abstract: A method of preventing egress of a vapor from an encapsulated volume can include forming a substantially impermeable vapor barrier (20) along an inner surface of the encapsulated volume. The encapsulated volume includes a permeable body (120) of comminuted hydrocarbonaceous material. Further, the vapor barrier (20) can include an insulating layer (24) capable of maintaining a temperature gradient of at least 400°F across the insulating layer (24). The permeable body (120) can be heated sufficient to liberate hydrocarbons therefrom and the hydrocarbons can be collected from the permeable body (120). The vapor barrier layer (20) can be a single or multiple layer construction, depending on the specific materials chosen.